NAPROXEN (NAPROXEN) — FDA Approval ANDA078250 (GLENMARK PHARMS LTD)
NAPROXEN (NAPROXEN) — FDA Approval ANDA078250 (GLENMARK PHARMS LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: NAPROXEN; Active ingredients: NAPROXEN; Application number: ANDA078250.
| Brand name | NAPROXEN |
|---|---|
| Active ingredients | NAPROXEN |
| Application number | ANDA078250 |
| Sponsor | GLENMARK PHARMS LTD |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 3 |
| First approval date | 20070328 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →